Literature DB >> 12212959

Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease.

C C Christensen1, M S Ryg, O Kåre Refvem, O Henning Skjønsberg.   

Abstract

Several publications have reported effects of hypobaric conditions in patients with chronic obstructive pulmonary disease. To the current authors' knowledge, similar studies concerning patients with restrictive lung disease have not been published. The effect of simulated air travel in a hypobaric chamber on arterial blood gases, blood pressure, and cardiac frequency during rest and 20 W exercise, and the response to supplementary oxygen in 17 patients with chronic restrictive ventilatory impairment has been investigated. Resting oxygen tension in arterial blood (Pa,O2) decreased from 10.4+/-1.6 kPa at sea level to 6.5+/-1.1 kPa at 2,438 m simulated altitude, and decreased further during light exercise in all patients (5.1+/-0.9 kPa). Pa,O2 at this altitude correlated positively with sea-level Pa,O2 and transfer factor of the lung for carbon monoxide (TL,CO), and negatively with carbon dioxide tension in arterial blood (Pa,CO2). Pa,O2 increased to acceptable levels with an O2 supply of 2 L x min(-1) at rest and 4 L x min(-1) during 20 W exercise. In conclusion, most of the patients with restrictive ventilatory impairment developed hypoxaemia below the recommended levels of in-flight oxygen tension in arterial blood during simulated air travel. Light exercise aggravated the hypoxaemia. Acceptable levels of oxygen tension in arterial blood, with only a minor increase in carbon dioxide tension in arterial blood, were obtained by supplementary oxygen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212959     DOI: 10.1183/09031936.02.00222302

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

2.  Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.

Authors:  L M Seccombe; P T Kelly; C K Wong; P G Rogers; S Lim; M J Peters
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 3.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

4.  Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation.

Authors:  Ana C Bradi; Marie E Faughnan; Matthew B Stanbrook; Eva Deschenes-Leek; Kenneth R Chapman
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

5.  Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry.

Authors:  Shoaib Fakhri; Kelly Hannon; Kelly Moulden; Ryan Peterson; Peter Hountras; Todd Bull; James Maloney; Teresa De Marco; Dunbar Ivy; Thenappan Thenappan; Jeffrey S Sager; John J Ryan; Sula Mazimba; Russel Hirsch; Murali Chakinala; Oksana Shlobin; Matthew Lammi; Dianne Zwicke; Jeffrey Robinson; Raymond L Benza; James Klinger; Daniel Grinnan; Stephen Mathai; David Badesch
Journal:  Pulm Circ       Date:  2020-11-10       Impact factor: 2.886

6.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

Review 7.  Prevention of Medical Events During Air Travel: A Narrative Review.

Authors:  Diane Naouri; Frederic Lapostolle; Claire Rondet; Olivier Ganansia; Dominique Pateron; Youri Yordanov
Journal:  Am J Med       Date:  2016-06-04       Impact factor: 4.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.